Daiichi Sankyo Aims To Double Net Profit In FY 2017, To $1.2 Billion
This article was originally published in PharmAsia News
Executive Summary
Daiichi Sankyo said it is targeting a $1.2 billion profit in the year ending March, 2018, a goal that would more than double its current annual net profit, thanks in part to its Ranbaxy subsidiary.